<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00839085</url>
  </required_header>
  <id_info>
    <org_study_id>8710</org_study_id>
    <nct_id>NCT00839085</nct_id>
  </id_info>
  <brief_title>Comparison of Ascorbic Acid and Grape Seed Extract in Oxidative Stress Induced by on Pump Heart Surgery</brief_title>
  <official_title>Effect of Ascorbic Acid and Grape Seed Extract &quot;Vitis Vinifera L.&quot; in Oxidative Stress Induced by on Pump Coronary Artery by Pass Grafting Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tabriz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tabriz University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study aimed to compare the effect of grape seed extract and ascorbic acid in oxidative stress
      induced by on pump coronary artery by pass grafting surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aimed to compare the effect of grape seed extract and ascorbic acid in oxidative
      stress induced by on pump coronary artery by pass grafting surgery.

      There are three groups in the study. 75 candidate of coronary artery by pass grafting surgery
      were assigned random allocation on the groups (25 in each group).

        1. Control

        2. GSE (100 mg/6h - PO, 24h before surgery)

        3. Vit C (25 mg/kg in pump circulation during surgery)
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">March 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LVEF</measure>
    <time_frame>Before and after CABG</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Antioxidant Capacity (TAC)</measure>
    <time_frame>Before ischemia, after ischemia, after reperfusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MDA</measure>
    <time_frame>Before, middle and after CABG</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GTX</measure>
    <time_frame>Before ischemia, after ischemia, after reperfusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOD</measure>
    <time_frame>Before ischemia, after ischemia, after reperfusion</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>CABG-Induced Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>normal procedure of CABG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: GSE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100 mg GSE every 6h /Po, starting one day before surgery (4 doses in 24h)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3: Vit C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 mg/kg through pump</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GSE</intervention_name>
    <description>grape seed extract (100 mg/6h), PO</description>
    <arm_group_label>2: GSE</arm_group_label>
    <other_name>Grape Seed Extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vit C (Ascorbic Acid)</intervention_name>
    <description>Vit C 25 mg/ kg</description>
    <arm_group_label>3: Vit C</arm_group_label>
    <other_name>Ascorbic Acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidates for elective CABG surgery with pump for first time

          -  3VD

        Exclusion Criteria:

          -  High risk patients

          -  Those who need another heart surgery beside CABG

          -  Urgent patients

          -  Diabetics

          -  Ischemic time more than 120 min
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hossein Babaei, Pharm D, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Drug Applied Research Center, Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naser Safaei, MD, Surgeon</last_name>
    <role>Study Chair</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masood Pezaeshkian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alireza Yaghobi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmad Reza Jodati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hossein Babaei, Pharm D, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rasoul Azarfarin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad Ali Sheikhalizadeh, CCP</last_name>
    <role>Study Director</role>
    <affiliation>Tabriz Univ Med Sci</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Research Center</name>
      <address>
        <city>Tabriz</city>
        <state>East Azerbaijan</state>
        <zip>51656-65811</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2009</study_first_submitted>
  <study_first_submitted_qc>February 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2009</study_first_posted>
  <last_update_submitted>February 9, 2009</last_update_submitted>
  <last_update_submitted_qc>February 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Naser Safaei</name_title>
    <organization>Cardiovascular Research Center</organization>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>on pump</keyword>
  <keyword>Grape seed extract</keyword>
  <keyword>Vit C</keyword>
  <keyword>Oxidative stress</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Grape Seed Extract</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

